According to a 1961 study, patients with addiction who got NAD+ at a moderate IV drip rate (no more than 35 drops per minute) reported "no distress" but those who received it at a quicker drip rate complained of headache and shortness of breath (18)
Restless leg syndrome is characterized by sensations in the legs such as pulling, throbbing or creeping
As of mid-2026, roughly 11% of American adults are using a GLP-1 medication for weight loss, up from 3% in 2024, and 91% are aware these drugs exist (Gallup National Health and Well-Being Index, July 2026)
We compared GLP-1RAs with SGLT2 inhibitors and metformin and found that GLP-1RAs significantly reduced the incidence of major CVEs and mortality rate compared with metformin and second- or third-line glucose-lowering medications
However, some patients have reported experiencing leg discomfort, restlessness, or twitching after starting or increasing the dose of Mounjaro
Thats my only real comment